{
     "PMID": "11158258",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20010315",
     "LR": "20171116",
     "IS": "0022-3042 (Print) 0022-3042 (Linking)",
     "VI": "76",
     "IP": "3",
     "DP": "2001 Feb",
     "TI": "5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex.",
     "PG": "865-71",
     "AB": "We used knockout mice and receptor antagonist strategies to investigate the contribution of the serotonin (5-hydroxytryptamine, 5-HT) 1B receptor subtype in mediating the effects of selective serotonin re-uptake inhibitors (SSRIs). Using in vivo intracerebral microdialysis in awake mice, we show that a single systemic administration of paroxetine (1 or 5 mg/kg, i.p.) increased extracellular serotonin levels [5-HT]ext in the ventral hippocampus and frontal cortex of wild-type and mutant mice. However, in the ventral hippocampus, paroxetine at the two doses studied induced a larger increase in [5-HT]ext in knockout than in wild-type mice. In the frontal cortex, the effect of paroxetine was larger in mutants than in wild-type mice at the 1 mg/kg, but not at 5 mg/kg. In addition, either the absence of the 5-HT1B receptor or its blockade with the mixed 5-HT1B/1D receptor antagonist, GR 127935, potentiated the effect of a single administration of paroxetine on extracellular 5-HT levels more in the ventral hippocampus than in the frontal cortex. These data suggest that 5-HT1B autoreceptors limit the effects of SSRIs on dialysate 5-HT levels at serotonergic nerve terminals.",
     "FAU": [
          "Malagie, I",
          "Trillat, A C",
          "Bourin, M",
          "Jacquot, C",
          "Hen, R",
          "Gardier, A M"
     ],
     "AU": [
          "Malagie I",
          "Trillat AC",
          "Bourin M",
          "Jacquot C",
          "Hen R",
          "Gardier AM"
     ],
     "AD": "Laboratoire de Neuropharmacologie UPRES EAD MENRT, Faculte de Pharmacie IFR-ISIT Institut de Signalisation et d'Innovation Therapeutique, Universite Paris-Sud, Chatenay-Malabry, France.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "England",
     "TA": "J Neurochem",
     "JT": "Journal of neurochemistry",
     "JID": "2985190R",
     "RN": [
          "0 (Antidepressive Agents, Second-Generation)",
          "0 (Autoreceptors)",
          "0 (Drug Combinations)",
          "0 (Oxadiazoles)",
          "0 (Piperazines)",
          "0 (Receptor, Serotonin, 5-HT1B)",
          "0 (Receptors, Serotonin)",
          "0 (Serotonin Antagonists)",
          "0 (Serotonin Uptake Inhibitors)",
          "2LLH6CEB40 (GR 127935)",
          "333DO1RDJY (Serotonin)",
          "41VRH5220H (Paroxetine)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antidepressive Agents, Second-Generation/pharmacology",
          "Autoreceptors/*physiology",
          "Drug Combinations",
          "Frontal Lobe/*drug effects",
          "Hippocampus/*drug effects",
          "Male",
          "Mice",
          "Mice, Knockout/genetics",
          "Microdialysis",
          "Oxadiazoles/pharmacology",
          "Paroxetine/pharmacology",
          "Piperazines/pharmacology",
          "Receptor, Serotonin, 5-HT1B",
          "Receptors, Serotonin/genetics/*physiology",
          "Reference Values",
          "Serotonin/*metabolism",
          "Serotonin Antagonists/pharmacology",
          "Serotonin Uptake Inhibitors/*pharmacology"
     ],
     "EDAT": "2001/02/07 11:00",
     "MHDA": "2001/03/17 10:01",
     "CRDT": [
          "2001/02/07 11:00"
     ],
     "PHST": [
          "2001/02/07 11:00 [pubmed]",
          "2001/03/17 10:01 [medline]",
          "2001/02/07 11:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "J Neurochem. 2001 Feb;76(3):865-71.",
     "term": "hippocampus"
}